Press & News

People are different and so is their cancer, patients should be treated individually.

Chairman of the 2cureX Board exercises all warrants within the framework of the 2018 incentive program

April 14, 2022

IR

2cureX AB (“2cureX”) hereby announces that the Chairman of the 2cureX Board Povl-Andre’ Bendz has chosen to use his rights to subscribe for shares in 2cureX AB by fully exercising the respective number of warrants in the warrant program 2018/2021.

The now finalized warrant program for Povl-Andre’ included 84.800 warrants. The program was established in 2018 shortly after 2cureX’s listing at Nasdaq First North. The total exercise price of the warrants amounts to SEK 712.230.

The total shareholding of Povl-Andre’ Bendz in 2cureX is now 189.258.